FinTechFunding

Bio-Gene Technology: Lands new US patent approval for Flavocide insect control

Bio-Gene Technology Lands new US patent approval for Flavocide insect control

  • Bio-Gene Technology (BGT) has landed a new US patent to expand the protection of its insecticide products
  • The patent relates to the company’s Flavocide product for the control of pesticide-resistant pests and will expire in July 2038
  • Bio-Gene says this extends its current coverage for its insecticide and pest control products in an agricultural environment
  • CEO Richard Jagger said with the US being such a large market for the company’s products, the patent strengthens Bio-Gene’s negotiation position for future deals
  • Bio-Gene shares are up 2.5 per cent to 8.2 cents at 11:38 am AEDT
Previous article
Recharge Metals: Secures $3m to fund Express lithium project, Quebec
Next article
Blinto: Raises €10.6M in Funding
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Talos and Nasdaq Strengthen On-Chain and Off-Chain Collateral Workflow

New partnership enhances digital asset handling and collateral management.Highlights: Talos and Nasdaq collaborate to streamline collateral workflows.Partnership aims...
FinTech

FCA Restricts Use of Sensitive Data in AI Trial with Palantir

Regulatory concerns arise over data handling protocols in AI trials.Highlights: FCA criticized for using sensitive data in AI...
FinTech

Bank of Ireland Strengthens AI Readiness for Staff Training

New initiatives prepare employees for an AI-driven banking landscape.Highlights: Bank of Ireland launches AI training initiatives for staff.Employees...
FinTech

MAS Develops AI Risk Management Toolkit to Strengthen Financial Sector

New toolkit aims to enhance risk management within Singapore's finance industry.Highlights: MAS launches an AI Risk Management Toolkit...